NovoCure Stock (NASDAQ:NVCR), Quotes and News Summary

Q: What sector and industry does NovoCure (NVCR) operate in?

NovoCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

NovoCure Stock (NASDAQ: NVCR) stock price, news, charts, stock research, profile.

Open	$16.220
Close	$16.470
Volume / Avg.	821.779K / 1.296M
Day Range	16.020 - 16.600
52 Wk Range	10.870 - 83.600
Market Cap	$1.766B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	70
Short Interest	6.71%
Days to Cover	5.19

Recent News

Novocure Stock Soars, Its Lung Cancer Electric Field Treatment Slows Progression To Brain, Data Shows

Novocure's Phase 3 METIS trial results: TTFields therapy, combined with supportive care, significantly prolongs time to intracranial progression for NSCLC brain metastases patients compared to supportive care alone

Vandana Singh

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

Avi Kapoor

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NovoCure (NVCR) stock?

You can purchase shares of NovoCure (NASDAQ: NVCR) through any online brokerage.

View our list of the best stock brokerages.

Who are NovoCure's (NVCR) competitors?

Other companies in NovoCure’s space includes: SI-BONE (NASDAQ:SIBN), Varex Imaging (NASDAQ:VREX), Envista Holdings (NYSE:NVST), Inari Medical (NASDAQ:NARI) and Alphatec Holdings (NASDAQ:ATEC).

What is the target price for NovoCure (NVCR) stock?

The latest price target for NovoCure (NASDAQ: NVCR) was reported by HC Wainwright & Co. on Thursday, May 2, 2024. The analyst firm set a price target for 22.00 expecting NVCR to rise to within 12 months (a possible 34.06% upside). 20 analyst firms have reported ratings in the last year.

Current Stock Price for NovoCure (NVCR)?

The stock price for NovoCure (NASDAQ: NVCR) is $16.41 last updated May 10, 2024 at 5:49 PM EDT.

Does NovoCure (NVCR) pay a dividend?

There are no upcoming dividends for NovoCure.

When is NovoCure (NASDAQ:NVCR) reporting earnings?

NovoCure’s Q2 earnings are confirmed for Thursday, July 25, 2024.

Is NovoCure (NVCR) going to split?

There is no upcoming split for NovoCure.

What sector and industry does NovoCure (NVCR) operate in?

NovoCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-